🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Drug Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers market the substance there before redirecting customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in individuals administering substances of uncertain source.

Some experts stated the popularity for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or prison.

Service Response and Material Elimination

According to the social media company, the service has taken down problematic material and prohibited associated keywords and query recommendations. The company stated it was committed to keeping the service secure and investing in enhancing enforcement strategies.

Digital Trading Operations

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of slimming results, glowing testimonials and detailed instructions for mixing or administering at home.

Within moments of entering one community, a seller posted WhatsApp details, where most purchases take place. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Product Details and Pricing

Inside these groups, messages show black plastic parcels with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is valid, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has previously seen patients injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to potentially serious medical dangers”.